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Abstract 
In recent years, dementia has been considered a public health priority and become a topic of 
major political interest. Recent reviews and studies have reported with varying degrees of 
alarm an impending and existing “dementia epidemic” with increasing predicted trends in 
prevalence and enormous numbers of people with dementia particularly in low- and middle- 
income countries (LMICs). However, robust evidence from dementia research in high-income 
countries suggests stable or decreased prevalence over the last decades. Current evidence is 
not sufficient to suggest increasing trends of prevalence in LMICs once variation in 
methodological factors and study populations are taken into account. Changes in diagnostic 
methods over the last decades substantially influence the identification of dementia cases with 
systematic difference between the resulting individual prevalence studies. Potential 
geographical variations at the country level might indicate potential risk factors at population 
levels or systematic difference in clinical application of dementia diagnosis. Although it is 
important and necessary to use information from dementia research for evidence-based 
policymaking, over-interpretation of results without carefully considering underlying factors 
could exaggerate the findings and influence policy planning in ways which do not serve 
current and future population best. Planning of dementia policy needs to take full cognisance 
of the provenance of the data being used and be integrated with policies which optimise 
health across the lifecourse. 
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1. Introduction 
In recent years, dementia has become a public health priority with substantial impact on not 
only individuals and their families but also health care, economic and welfare systems of 
whole societies [1]. In 1980s, the governments of developed countries started to express 
concern about rapid population ageing with dementia and cognitive decline being important 
causes of disability in later life [2]. To investigate dementia in general populations, several 
epidemiological studies were conducted in North America and Western Europe between 
1980s and 1990s. The findings provided important evidence for health policy planning [3, 4]. 
Awareness of dementia has increased the need for good data extending from high-income to 
low- and middle-income countries (LMICs) which now contain large number of ageing 
population with emerging epidemics of non-communicable diseases. It has also moved from 
professional to public arenas involving the active campaigns, lobbying of charities and 
awareness of business opportunities. Dementia has become a topic of major political interest. 
In the UK, the Prime Minister’s Challenge on Dementia commits to delivery of major 
improvements in dementia care and research by 2015 [5]. The G8 summit held in December 
2013 called for international action to address the problem of dementia and brought together 
policy makers, researchers, pharmaceutical companies and charities from around the world [6]. 
The summit agreed on an increased spends on dementia research and the development of 
international collaborations, information and data sharing.  
6 
 
 
This surge in interest in ageing populations and health care provisions can and will affect 
resource availability for dementia research, which should provide better evidence-based 
strategies for policy planning. Recent reviews and studies have reported with varying degrees 
of alarm an impending and existing “dementia epidemic” with increasing predicted trends in 
prevalence and enormous numbers of people with dementia particularly in developing 
countries [7]. However, these somewhat hyperbolic statements of a worsening situation need 
to be constantly examined and updated.  
 
2. Time trends and geographical variations in dementia 
Over the last decades, several reviews or studies have attempted to investigate the 
epidemiology of dementia in national and international populations with the exploration of 
temporal and geographical variations of prevalence. Here we summarise existing evidence of 
epidemiology of dementia worldwide drawing on relevant systematic reviews (or 
meta-analysis) and recent epidemiological studies designed to compare the changing 
epidemiology of dementia in the well-defined populations. Consideration of very different 
economic and social situations across countries exists, thus synthesis of current evidence from 
dementia research is reported according to country income levels (high vs low- and 
middle-income countries). 
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High-income countries: Western Europe, North America and Japan 
Governments of high-income countries have been aware of demographic ageing and potential 
increase in dementia since 1980s. The EURODEM collaborative study synthesised the results 
of community-based studies in European countries between 1980s and 1990s [3]. The 
prevalence of dementia steadily increased with age and showed similar estimates and patterns 
across different countries. These results were used to predict the number of people with 
dementia over years and assist in policy making and service provision while few 
epidemiological surveys were conducted in the post-EURODEM period [8, 9]. In the last five 
years, a small number of new studies which aimed to provide updated estimates and 
investigate changes in prevalence have repeated earlier methods in the same areas. The 
findings of these studies suggest stable or reduced prevalence of dementia over the last 20 
years [10-12]. The number of people with dementia in European countries is considered to be 
lower than the estimates in 1990s had predicted given the changes in age structures of these 
populations. 
 
Similar to Western Europe, the results of early prevalence studies in the US have been used to 
estimate nationwide prevalence using the projection methodology with different assumptions 
of demographic ageing [13-16]. In contrast, the two studies comparing repetitive surveys 
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across different time periods also reported a stability or decline of the prevalence of dementia 
and cognitive impairment over time [17-20].  
 
In East Asia, Japan also experienced the pressure of population ageing and conducted early 
dementia research in 1980s. In contrast to the US and Europe, recent reviews have reported an 
increasing trend of dementia prevalence in Japan over last decades [21, 22]. However, this 
finding might be driven by variation of study methods and characteristics of study populations 
over time [21, 23]. Despite potential bias in study designs and analysis methods, some studies 
applying the similar study methods in the small areas reported stability of dementia 
prevalence from 1980s to 1990s but with high prevalence in surveys after 2000 [22, 24, 25]. 
The prevalence of dementia in Japan could have potentially increased in recent eight to ten 
years but have been relatively stable before 2000. In South Korea, the estimated prevalence 
was generally higher than other developed countries since mid-1990s without obvious 
difference between various diagnostic criteria [26]. 
 
Lower- and middle- income countries: global prevalence of dementia and China 
The 10/66 Dementia Research Group has conducted investigation of dementia prevalence in 
numerous urban and rural sites in Latin American, India and China using consistent 
measurement methods [27]. Estimated prevalence of dementia has varied across countries and 
9 
 
within countries between urban and rural areas. The influence of diagnostic criteria (DSM-IV 
and 10/66 algorithm) on prevalence estimates has been reported to be substantial in the 
populations of developing countries [28]. 
 
To investigate global burden of dementia and the prevalence in LMICs, the 10/66 Dementia 
Research Group conducted a systematic review of the worldwide literature from 1980 to 2009 
[29]. The results were included in the WHO report of dementia in 2012 [1]. A four-fold 
variation was found in age-adjusted prevalence of dementia in populations aged 60 and over 
across regions. Although substantial variation of methodological factors was inevitable, lower 
estimated prevalence was generally found in African regions while Latin America had 
particularly high prevalence [1, 30]. The regions without sufficient prevalence data including 
Middle East, Eastern and Central Europe, Central Asia and Oceania were based on relevant 
estimates from the 2005 Delphi Consensus study [29, 31]. The data have been updated in 
2013 including newer studies in East Asia and Africa with an estimated prevalence which is 
higher than the original report [7]. The number of people living with dementia worldwide is 
estimated to have been nearly 45 million in 2013 and expected to increase to 75 million in 
2030 and 135 million in 2050. However, these higher estimates could be substantially driven 
by recent prevalence studies using newer diagnostic standards based on recent reviews of 
Chinese studies applied to the massive Chinese population. 
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With the largest populations in the world, China started to be concerned about the impact of 
demographic ageing and dementia more recently. Several reviews have summarised a number 
of studies since late 1980s [32-35]. The authors report a substantial increase of dementia 
prevalence in mainland China with a doubling of age-specific prevalence from 1990 to 2010 
[32, 34]. However, this pattern could be largely attributed to variation of study designs and 
methodological factors as these are significantly related to heterogeneity of prevalence studies 
in China [35, 36]. Higher prevalence was found in the recent studies using newer diagnostic 
criteria (DSM-IV and 10/66 algorithm) than those using older diagnostic criteria (DSM-III, 
DSM-III-R and CCMD). The increase of dementia prevalence in China is considered 
therefore to have been amplified by these changes in methodology over time.  
 
In a review of prevalence studies in Brazil from 1990 to 2010, over-estimated prevalence was 
found in the research with poor quality of study designs such as biased sampling methods, 
unstandardised measurements and assessors [37]. Methodological variations and quality of 
study can considerably modify prevalence estimates. 
 
3. Evidence for time trends and geographical variations 
Instead of expected increasing trends, robust evidence from dementia research in high-income 
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countries suggests stable or decreased prevalence over the last decades. The results of recent 
studies actually suggest that the number of people with dementia in current European 
populations is stable or lower than the estimates in earlier years. Increasing trends of 
prevalence have been reported in the low- and middle-income countries mainly based on 
pooled estimates of the individual studies without taking methodological variations and 
characteristics of study populations into account. Changes in diagnostic criteria over the last 
30 years substantially affect the identification of dementia cases with systematic difference 
between the prevalence studies using newer and older criteria. Broader definitions of 
dementia and cognitive decline in recent years could include more suspected and borderline 
cases with increasing prevalence. Broader definitions of dementia and cognitive decline in 
recent years seem likely to include more suspected and borderline cases with increasing 
prevalence particularly in the changes the Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition (DSM-V). The definition of “neurocognitive disorder”, which replaces 
the term “dementia”, could substantially increase the proportion of people diagnosed with 
mild cognitive decline. New studies using the DSM-V criteria are expected to measure a 
higher prevalence of dementia and cannot be directly compared with the previous estimates. 
In developing countries, where dementia research is associated with the development of 
diagnostic methods and medical services, increasing trends and estimated numbers of people 
with dementia might be substantially attributed to changes in diagnostic methods rather than 
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true increases over time.  
 
Furthermore, societal changes and variations in methodological factors can also importantly 
moderate the time trends of dementia prevalence. Even though some studies have had to 
control the influence of various methodological factors, there could be the remaining variation 
“within diagnostic criteria”. Trainings of clinicians and application of diagnostic methods 
have also changed with time even if subtly. In recent years, the rise of awareness campaigns, 
changing knowledge and attitude to dementia in professionals and public have made whole 
societies better prepared to discuss this later life condition. Changes in the social environment 
might potentially increase the identified number of people with dementia who have previously 
been considered as a natural stage of ageing and rarely recorded in medical histories. Such 
variations in diagnostic practice are difficult to measure and the findings of epidemiological 
studies need to be interpreted very carefully with the consideration of not only design and 
methods but also social contexts of investigations and health care.  
 
The findings of the 10/66 study indicate geographical variation of dementia prevalence across 
developing countries and areas. Although the four-fold difference of prevalence at country 
level was found in the global review, the influence of methodological factors and the 
development of social environment could potentially moderate the estimates [1, 30]. Recent 
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meta-analysis reviews with taking methodological difference into account suggest an impact 
on prevalence in different levels of geographical units [34, 38]. Similar to time trends, 
evidence for geographical variation based on literature reviews has the limitation of not being 
able to completely adjust for the heterogeneity between individual studies [39]. Definitions of 
urban/ rural areas and the sizes of city, county and other geographical units can vary 
considerably across countries and cause difficulty in comparisons.  
 
4. Challenges and responses 
Since dementia has become a topic of political interest, evidence for time trends and spatial 
variation has been reported from many epidemiological studies. With this increasing interest 
and popularity, the conclusions of “enormous numbers”, “increasing patterns” and 
“substantial burden of disease” could be more appealing than any measured reflection on 
impact of methodologies and conflicting evidence as they can be used by charities, politicians 
and interested parties (clinicians and specialists) to attract more attention from both public 
and private sectors including potential investment from pharmaceutical companies and 
healthcare businesses. Although it is important and necessary to use the information from 
dementia research for evidence-based policymaking, over-interpretation of results without 
carefully considering underlying factors could exaggerate the findings and influence policy 
planning in ways which do not serve current and future populations best.  
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Current evidence is not sufficient to suggest increasing trends of prevalence in LMICs taking 
variations of methodological factors and study populations into account. As health systems in 
LMICs are still vulnerable with limited resources, over-emphasis on “dementia epidemic” and 
misleading policy planning might have unintended negative influences on health systems. In 
the G8 summit, international strategies for dementia were linked to previous experiences of 
“HIV/ AIDS” and “climate change” [6]. Although the epidemic of HIV/ AIDS in Africa has 
been addressed successfully, specific funding for HIV/ AIDS projects has driven the priority 
of health policy and has been reported to seriously interfere with the development of whole 
societal health systems in these lower income countries [40]. Even though the increasing 
number of older people is a substantial concern in LMICs, the priority policy should focus on 
addressing major determinants of health and establishing complete health care systems for 
basic needs of whole population as they can be beneficial to health of whole societies thus 
reducing the impact and burden of non-communicable diseases and dementia now and into 
the future.  
 
Current evidence from high-income countries is actually more optimistic than previous 
prediction. The reduction of dementia risk in European and the US populations over the last 
decades is considered to be likely to be associated with earlier life better education, healthy 
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lifestyle factors, decreased vascular diseases and other chronic illnesses [20]. Public health 
policies aimed at whole populations and health care provisions could modify dementia risk in 
later life over years. This implies that a pure “dementia-orientated policy” could be 
problematic for effective prevention. Based on the evidence from observational studies, over 
attention and specific focus on dementia policy and research in secondary (screening) and 
tertiary (cure and therapy) care might improve individual care provision but have limited 
influence on population health as key confirmed risk factors and protective features for 
dementia are related to health conditions in early and middle ages. Policy responses to 
dementia need not only to consider improvement of care delivery but also integrate with 
general public health issues (such as smoking, alcohol consumption, physical activity and 
associations of head injuries) and interventions to reduce impact of other non-communicable 
diseases. 
 
Although the prevalence of dementia has been investigated in several low- and 
middle-income countries, there is no available information in the certain regions such as 
Middle East, Eastern and Central Europe. High prevalence of cardiovascular diseases in these 
areas could play an important role on modifying the risk of dementia over time with potential 
geographical variation across countries [41]. To provide robust evidence for time trends in 
LIMCs, it is important to conduct longitudinal studies with rigorous study designs and quality 
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control over time and to investigate the trends in prevalence, trajectories of cognitive function 
sensitive to the sociocultural environment and changes in risk factors across birth cohorts. 
Identifying important and specific risk factors in the populations of LIMCs could be an 
evidence-based and efficient approach for policy planning. 
 
5. Conclusions 
Interpretation of new results and comparison with earlier studies in the field of dementia need 
additional consideration of societal changes and research contexts. Stable or reduced 
prevalence of dementia has been suggested from studies in high-income countries while lack 
of comparable information over time is a major issue in low- and middle-income countries. 
Geographical variations at country level might indicate potential risk factors at population 
levels or systematic difference in clinical application of dementia diagnosis. Changing 
profiles of potential risk factors in early and middle life could importantly moderate the 
occurrence of dementia in later life. Planning of dementia policy needs to be integrated with 
attention to policies which optimise health across the lifecourse. 
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